PEBP1 and asthma: Patients with PEBP1 levels <1112.0 pg/mL had a significantly higher risk of severe asthma in Model 1 (OR = 216.15, 95% CI: 1.92–215,555.09, and p < 0.05) and Model 3 (OR = 227.57, 95% CI: 2.03–210,000.33, and p < 0.05).